Literature DB >> 3498686

The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system.

G Los1, R A De Weger, R M Moberts, H Van Loveren, R J Sakkers, W Den Otter.   

Abstract

In different murine systems, delayed-type hypersensitivity (DTH) swelling responses at 24-48 hr after antigen challenge were preceded by an early 2-hr swelling response. The 24-hr DTH response is thought to depend on this early (DTH-initiating) hypersensitivity response. In this paper we show that in the syngeneic DBA/2-SL2 murine tumour system only an early 2-hr swelling response can be evoked. This early hypersensitivity response was tumour specific and serotonin dependent. The early hypersensitivity response in contact hypersensitivity has been ascribed to antigen-specific T-cell factors. To test whether similar T-cell factors were involved in the early hypersensitivity response in this syngeneic tumour system, we have transferred lymph node, spleen lymphocytes and serum from immunized mice into naive recipients. The serum was fractionated in two fractions, a 50,000-80,000 MW fraction, and a 120,000-190,000 MW fraction. In recipients of lymphocytes, total serum and the 50,000-80,000 MW fraction of the serum, an early hypersensitivity response can be evoked. So, these data suggest the involvement of specific T-cell factors in the development of an early hypersensitivity response against syngeneic tumour cells. Despite the development of an early (DTH initiating) hypersensitivity swelling response these immunized animals cannot develop a classical 24-hr swelling response. This absence of the 24-hr response in the presence of the 2-hr response is discussed in relation to the frequently observed immune suppression in tumour-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498686      PMCID: PMC1453719     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.

Authors:  H F Dullens; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Induction of specific macrophage cytotoxicity.

Authors:  R A De Weger; W Den Otter
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.

Authors:  H Van Loveren; K Kato; R Meade; D R Green; M Horowitz; W Ptak; P W Askenase
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

4.  Host macrophages are involved in systemic adoptive immunity against tumors.

Authors:  H Van Loveren; M Snoek; W den Otter
Journal:  Experientia       Date:  1982-04-15

5.  Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems.

Authors:  D M Lubaroff; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

6.  Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells.

Authors:  W Ptak; P W Askenase; R W Rosenstein; R K Gershon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.

Authors:  H Van Loveren; W Den Otter; R Meade; P M Terheggen; P W Askenase
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

8.  Immune serum from mice contact-sensitized with picryl chloride contains an antigen-specific T cell factor that transfers immediate cutaneous reactivity.

Authors:  H Van Loveren; R E Ratzlaff; K Kato; R Meade; T A Ferguson; G M Iverson; C A Janeway; P W Askenase
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

9.  Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharide.

Authors:  R A de Weger; H van Loveren; J W de Groot; R Rangarajan; W den Otter
Journal:  Immunobiology       Date:  1986-04       Impact factor: 3.144

10.  Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells.

Authors:  Y A Mekori; G L Weitzman; S J Galli
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  5 in total

1.  Initial immunochemical characterization of specific macrophage-arming factor.

Authors:  R A De Weger; R J Vandebriel; H Slager; D Mans; H Van Loveren; B Wilbrink; H F Dullens; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.

Authors:  H F Dullens; R A De Weger; M Van der Maas; P J Den Besten; R J Vandebriel; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.

Authors:  J J Bergers; W Den Otter; J W De Groot; A W De Blois; H F Dullens; P A Steerenberg; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytes.

Authors:  G Los; R A De Weger; D T Van den Berg; R Sakkers; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 5.  A subset of AID-dependent B-1a cells initiates hypersensitivity and pneumococcal pneumonia resistance.

Authors:  Phillip W Askenase; Krzysztof Bryniarski; Vipin Paliwal; Frank Redegeld; Thomas Groot Kormelink; Steven Kerfoot; Andrew T Hutchinson; Henk van Loveren; Regis Campos; Atsuko Itakura; Monika Majewska-Szczepanik; Natsuo Yamamoto; Katarzyn Nazimek; Marian Szczepanik; Wold Ptak
Journal:  Ann N Y Acad Sci       Date:  2015-12       Impact factor: 5.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.